Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020
Scope of the Report
The report titled “Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020” provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Azole, Echinocandins and Polyene.
The report analysis the invasive fungal infection market extensively with the market size, in terms of value along with the market segments and the major products in the market. This section also provides information about the regional market share of the global invasive fungal infection market. The report provides detailed regional analysis of the United States, Europe and Latin America. The regional analysis of the antifungal market includes market size by value along with the geographic overview of the market in the concerned region.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global antifungal market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global antifungal market is stiff and dominated by the big players like Pfizer. Further, key players of the market, Merck and Scynexis are also profiled with their financial information and respective business strategies.
Regional Coverage
The global antifungal market witnessed an upsurge at a significant CAGR during 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The market is spread across the globe with the United States and Europe dominating the market, while Asia-Pacific and Latin America market are the fastest growing markets.
The antifungal market can be segmented on the basis of types of drugs into Polyene, Azole and Echinocandins. The Azole class of antifungals dominates the market followed, by Echinocandins and Polyene. Azoles are broadly categorized as Voricanazole, Imidazole, Triazole and Thiazoles. Of which, Voricanazole govern the market. Echinocandins antifungal class is subjugated by Caspofungin, while other antifungals include Micafungin, and Anidulafungin. The Polyene antifungal agents include Amphotericin B, Nystatin, and Natamycin. Though, Amphotericin B is the only widely used agent in the market.
The fungal infections do not usually result in severe ailment, but in people with weak immune system, minor fungal infections can move in the bloodstreams and conquer critical organs leading to the damage, called as invasive fungal infection. The global market for the invasive fungal infection increased significantly during 2010-2015 and is expected to upsurge further.
The major growth drivers for the global antifungal market are: the rise in the incidences of fungal infection, aging population and unhygienic conditions all over the world. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: antifungal resistance, traditional treatments for fungal infection, side-effects of antifungal medication and antifungal development failures Some of the recent trends in the market include technological advancement, growth in resistant strains and generic competition.
The report titled “Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020” provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Azole, Echinocandins and Polyene.
The report analysis the invasive fungal infection market extensively with the market size, in terms of value along with the market segments and the major products in the market. This section also provides information about the regional market share of the global invasive fungal infection market. The report provides detailed regional analysis of the United States, Europe and Latin America. The regional analysis of the antifungal market includes market size by value along with the geographic overview of the market in the concerned region.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global antifungal market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global antifungal market is stiff and dominated by the big players like Pfizer. Further, key players of the market, Merck and Scynexis are also profiled with their financial information and respective business strategies.
Regional Coverage
- United States
- Europe
- Latin America
- Pfizer, Inc.
- Merck Co., Inc.
- Scynexis, Inc.
The global antifungal market witnessed an upsurge at a significant CAGR during 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The market is spread across the globe with the United States and Europe dominating the market, while Asia-Pacific and Latin America market are the fastest growing markets.
The antifungal market can be segmented on the basis of types of drugs into Polyene, Azole and Echinocandins. The Azole class of antifungals dominates the market followed, by Echinocandins and Polyene. Azoles are broadly categorized as Voricanazole, Imidazole, Triazole and Thiazoles. Of which, Voricanazole govern the market. Echinocandins antifungal class is subjugated by Caspofungin, while other antifungals include Micafungin, and Anidulafungin. The Polyene antifungal agents include Amphotericin B, Nystatin, and Natamycin. Though, Amphotericin B is the only widely used agent in the market.
The fungal infections do not usually result in severe ailment, but in people with weak immune system, minor fungal infections can move in the bloodstreams and conquer critical organs leading to the damage, called as invasive fungal infection. The global market for the invasive fungal infection increased significantly during 2010-2015 and is expected to upsurge further.
The major growth drivers for the global antifungal market are: the rise in the incidences of fungal infection, aging population and unhygienic conditions all over the world. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: antifungal resistance, traditional treatments for fungal infection, side-effects of antifungal medication and antifungal development failures Some of the recent trends in the market include technological advancement, growth in resistant strains and generic competition.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Introduction to Fungal Infection
2.2 Antifungal Agents Overview
2.3 Antifungal Drugs
2.3.1 Azole Class of Antifungal Drugs
2.3.2 Echinocandins Class of Antifungal Drugs
2.3.3 Polyene Class f Antifungal Drugs
2.3.4 Allylamines Class of Antifungal Drugs
3. GLOBAL MARKET ANALYSIS
3.1 Global Antifungal Market by Value
3.2 Global Antifungal Market by Drug Segments
3.2.1 Global Azole Class of Antifungal Drug Market by Value
3.2.2 Global Echinocandins Class of Antifungal Drug Market by Value
3.2.3 Global Polyene Class of Antifungal Drug Market by Value
3.3 Global Antifungal Market by Region
3.3.1 The U.S. Antifungal Market by Value
3.3.2 Europe Antifungal Drug Market by Value
3.3.3 Latin America Antifungal Drug Market by Value
4. INVASIVE FUNGAL INFECTION MARKET
4.1 Invasive Fungal Infection
4.2 Invasive Fungal Infection Epidemiology
4.3 Invasive Fungal Infection Cases
4.4 Global Invasive Fungal Infection Market Analysis
4.4.1 Global Invasive Fungal Infection Market by Value
4.4.2 Global Invasive Fungal Infection Market by Segments and Products
4.4.3 Global Invasive Fungal Infection Market by Region
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Incidences of Fungal Infection
5.1.2 Upsurge in Aging Population
5.1.3 Increasing Unhygienic Conditions
5.2 Challenges
5.2.1 Antifungal Resistance
5.2.2 Traditional Treatment for Fungal Infection
5.2.3 Side-Effects of Antifungal Medication
5.2.4 Antifungal Development Failures
5.3 Market Trends
5.3.1 Technological Advancements
5.3.2 Growth in Resistant Strains
5.3.3 Generic Competition
6. COMPETITIVE LANDSCAPE
6.1 Global Antifungal Market Major Players
6.2 Global Antifungal market Emerging Players
7. COMPANY PROFILING
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Scynexis, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
2. INTRODUCTION
2.1 Introduction to Fungal Infection
2.2 Antifungal Agents Overview
2.3 Antifungal Drugs
2.3.1 Azole Class of Antifungal Drugs
2.3.2 Echinocandins Class of Antifungal Drugs
2.3.3 Polyene Class f Antifungal Drugs
2.3.4 Allylamines Class of Antifungal Drugs
3. GLOBAL MARKET ANALYSIS
3.1 Global Antifungal Market by Value
3.2 Global Antifungal Market by Drug Segments
3.2.1 Global Azole Class of Antifungal Drug Market by Value
3.2.2 Global Echinocandins Class of Antifungal Drug Market by Value
3.2.3 Global Polyene Class of Antifungal Drug Market by Value
3.3 Global Antifungal Market by Region
3.3.1 The U.S. Antifungal Market by Value
3.3.2 Europe Antifungal Drug Market by Value
3.3.3 Latin America Antifungal Drug Market by Value
4. INVASIVE FUNGAL INFECTION MARKET
4.1 Invasive Fungal Infection
4.2 Invasive Fungal Infection Epidemiology
4.3 Invasive Fungal Infection Cases
4.4 Global Invasive Fungal Infection Market Analysis
4.4.1 Global Invasive Fungal Infection Market by Value
4.4.2 Global Invasive Fungal Infection Market by Segments and Products
4.4.3 Global Invasive Fungal Infection Market by Region
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Rising Incidences of Fungal Infection
5.1.2 Upsurge in Aging Population
5.1.3 Increasing Unhygienic Conditions
5.2 Challenges
5.2.1 Antifungal Resistance
5.2.2 Traditional Treatment for Fungal Infection
5.2.3 Side-Effects of Antifungal Medication
5.2.4 Antifungal Development Failures
5.3 Market Trends
5.3.1 Technological Advancements
5.3.2 Growth in Resistant Strains
5.3.3 Generic Competition
6. COMPETITIVE LANDSCAPE
6.1 Global Antifungal Market Major Players
6.2 Global Antifungal market Emerging Players
7. COMPANY PROFILING
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Scynexis, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
LIST OF FIGURES
Figure 1: Global Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 2: Global Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 3: Global Antifungal Market by Drug Segments; 2015 (%)
Figure 4: Global Azole Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 5: Global Azole Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 6: Global Echinocandins Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 7: Global Echinocandins Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 8: Global Polyene Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 9: Global Polyene Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 10: Global Antifungal Market by Region; 2015 (%)
Figure 11: The U.S. Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 12: Europe Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 13: Latin America Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 14: Invasive Fungal Infection Epidemiology
Figure 15: Global Invasive Fungal Infection Market by Value; 2010-2015 (US$ Billion)
Figure 16: Global Invasive Fugal Infection Market by Drug Segments; 2014 (%)
Figure 17: Global Invasive Fungal Infection Market by Products; 2014 (%)
Figure 18: Global Invasive Fungal Infection Market by Region; 2015 (%)
Figure 19: Global Aging Population;2010-2015E (Million)
Figure 20: Pfizer Total Revenue; 2011-2015 (US$ Billion)
Figure 21: Pfizer Total Revenues by Segments; 2015 (%)
Figure 22: Pfizer Total Revenues by Region; 2015 (%)
Figure 23: Merck Total Sales; 2011-2015 (US$ Billion)
Figure 24: Merck Total Sales by Segments; 2015 (%)
Figure 25: Merck Total Sales by Region; 2015 (%)
Figure 26: Scynexis Total Revenue; 2012-2015 (US$ Million)
Figure 27: Scynexis Research and Development Expense; 2013-2015 (US$ Million)
Table 1: Azole Class of Antifungal Drug Types
Table 2: Echinocandins Class of Antifungal Drug Types
Table 3: Polyene Class of Antifungal Drug Types
Table 4: Global Antifungal Market Major Players by Drug Type
Table 5: Global Antifungal Market Emerging Players
Figure 1: Global Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 2: Global Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 3: Global Antifungal Market by Drug Segments; 2015 (%)
Figure 4: Global Azole Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 5: Global Azole Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 6: Global Echinocandins Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 7: Global Echinocandins Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 8: Global Polyene Class of Antifungal Market by Value; 2012-2015 (US$ Billion)
Figure 9: Global Polyene Class of Antifungal Market by Value; 2016E-2020E (US$ Billion)
Figure 10: Global Antifungal Market by Region; 2015 (%)
Figure 11: The U.S. Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 12: Europe Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 13: Latin America Antifungal Market by Value; 2015-2020E (US$ Billion)
Figure 14: Invasive Fungal Infection Epidemiology
Figure 15: Global Invasive Fungal Infection Market by Value; 2010-2015 (US$ Billion)
Figure 16: Global Invasive Fugal Infection Market by Drug Segments; 2014 (%)
Figure 17: Global Invasive Fungal Infection Market by Products; 2014 (%)
Figure 18: Global Invasive Fungal Infection Market by Region; 2015 (%)
Figure 19: Global Aging Population;2010-2015E (Million)
Figure 20: Pfizer Total Revenue; 2011-2015 (US$ Billion)
Figure 21: Pfizer Total Revenues by Segments; 2015 (%)
Figure 22: Pfizer Total Revenues by Region; 2015 (%)
Figure 23: Merck Total Sales; 2011-2015 (US$ Billion)
Figure 24: Merck Total Sales by Segments; 2015 (%)
Figure 25: Merck Total Sales by Region; 2015 (%)
Figure 26: Scynexis Total Revenue; 2012-2015 (US$ Million)
Figure 27: Scynexis Research and Development Expense; 2013-2015 (US$ Million)
Table 1: Azole Class of Antifungal Drug Types
Table 2: Echinocandins Class of Antifungal Drug Types
Table 3: Polyene Class of Antifungal Drug Types
Table 4: Global Antifungal Market Major Players by Drug Type
Table 5: Global Antifungal Market Emerging Players
